Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine versus sufentanil combined with propofol for anesthesia induction in elderly elective surgery patients
ChiCTR2400094676Phase 4Not yet recruiting
- Sponsor
- Jiangxi Provincial People's Hospital
- Start
- Dec 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of esketamine, sufentanil, propofol, remimazolam and lidocaine (2 arms), sponsored by Jiangxi Provincial People's Hospital. Primary endpoints: Mean arterial pressure and Bispectral Index. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
esketaminesufentanilpropofolremimazolamlidocaine
Beyond the preview
Go deeper on ChiCTR2400094676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400094676.